Skip to main content
. 2024 Sep 25;19(9):e0311084. doi: 10.1371/journal.pone.0311084

Fig 4.

Fig 4

A. Progression-free survival based on AFP response. AFP responders showed significantly longer PFS than non-responders (N = 62, median PFS, 6.8 vs. 2.5 months, p = 0.015), B. Progression-free survival based on DCP response. DCP responders showed significantly longer PFS than non-responders (N = 87, median PFS, 6.3 vs. 2.3 months, p = 0.013).